ESR1 and metastatic malignant neoplasm in the lymph nodes: According to the univariate analysis, tumor size, lymph node metastasis, lymphovascular invasion, ER status, PR status, and radiotherapy were significant factors for iDFS (P < 0.05) (Table 1).